All > Massachusetts Investigators

Maureen Okam, MD, MPH

Brigham and Women's Hospital

Boston, Massachusetts - 02115 (617-732-6237)

CLINICAL TRIALS 2
CONDITIONS1
INTERVENTIONS2
SINCE2009

Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease

April 2010 - April 2012

Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease

October 2009 - October 2012

Anemia, Sickle Cell

Vorinostat

Lexiscan

Learn about TrialX Patient Recruitment services

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Maureen Okam, MD, MPH

Brigham and Women's Hospital

Massimo Loda, MD

Suzanne Shusterman

Patrick Y. Wen, MD

Lewis B. Silverman, MD

Kay Kehoe, Coordinator

Jennifer Brown, MD

Rachel A. Freedman

Edwin P. Alyea, MD

F. Stephen Hodi, MD

Beth A. Overmoyer, MD, FACP